Allogenic haematopoietic stem cell transplantation (allo-HSCT) can induce bone marrow fibrosis regression in patients with myelofibrosis (MF) however, the effect on the skeleton is unclear. Here, the authors perform in-depth, longitudinal evaluation of skeletal homeostasis following allo-HSCT in patients with MF using high-resolution imaging and bone biopsy analysis.
- Mathias Schäfersküpper
- Alexander Simon
- Tim Rolvien